CERO THERAPEUTICS HLDGS INC CERO
COM · Common Stock · CUSIP 71902K402
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersSouth San Francisco, CA
- FilingsSEC EDGAR
0
institutional holders
-11 vs Q3 2025
—reported value*
0 new
0 added
0 reduced
11 sold out
net sold ≈ $798.7k (-157.0k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q4 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q2 2025 | 9 |
| Q3 2025 | 11 |
| Q4 2025 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2025 | 5 | 2 |
| Q4 2025 | 0 | 11 |
Biggest buyers
| None |
Biggest sellers
| Parallel Advisors, LLC | Sold out | -121.0k |
| ARCH Venture Management, LLC | Sold out | -22.4k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Sold out | -10.2k |
| Tower Research Capital LLC (TRC) | Sold out | -1.3k |
| FNY Investment Advisers, LLC | Sold out | -1.1k |
| CITIGROUP INC | Sold out | -968 |
| SBI Securities Co., Ltd. | Sold out | -18 |
| UBS Group AG | Sold out | -6 |
| JONES FINANCIAL COMPANIES LLLP | Sold out | -3 |
| BANK OF AMERICA CORP /DE/ | Sold out | -3 |
Insider purchases and sales in Q4 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q4 2025.
Holders, Q4 2025
| Manager | Shares | Change |
|---|